PDF Cover

Cryopreservation Systems Market

Cryopreservation Systems Market

The market for Cryopreservation Systems was estimated at $2.5 billion in 2024; it is anticipated to increase to $4.8 billion by 2030, with projections indicating growth to around $8.4 billion by 2035.

Report ID:DS1801328
Author:Debadatta Patel - Senior Consultant
Published Date:July 2025
Datatree
Life Science
Medical Device
Cryopreservation Systems
Share
Report Summary
Table of Contents
Methodology
Market Data

Global Cryopreservation Systems Market Outlook

Revenue, 2024

$2.5B

Forecast, 2034

$7.5B

CAGR, 2024 - 2034

11.7%
The Cryopreservation Systems industry revenue is expected to be around $2.8 billion in 2025 and expected to showcase growth with 11.7% CAGR between 2025 and 2034. The steady rise in the cryopreservation systems markets growth can be attributed to driving factors at play. To begin with the consistent demand for biotechnologies like IVF treatments, stern cell research and pharmaceutical development has heightened the importance and relevance of cryopreservation systems in today's market. These systems are consistently being embraced due to their function in preserving biological components such, as structures, cells, tissues or organelles suspended at ultra low temperatures to ensure their structural integrity and operational efficiency. The progress in healthcare and biotech sectors along, with the increasing recognition of the advantages of cryopreservation is bolsterinig its market standing and importance more.

Cryopreservation systems play a role in today's research and biotechnology field by assisting in storing and protecting biological cells and tissues at extremely low temperatures to slow down biological processes effectively, for long term preservation without causing harm.

Cryopreservation Systems market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2024-2034

Market Key Insights

  • The Cryopreservation Systems market is projected to grow from $2.5 billion in 2024 to $7.5 billion in 2034. This represents a CAGR of 11.7%, reflecting rising demand across Stem Cell Research, Organ Transplants and In Vitro Fertilization.
  • Thermo Fisher Scientific Inc., Brooks Automation Inc., Chart Industries Inc. are among the leading players in this market, shaping its competitive landscape.
  • U.S. and Germany are the top markets within the Cryopreservation Systems market and are expected to observe the growth CAGR of 8.5% to 12.3% between 2024 and 2030.
  • Emerging markets including Brazil, India and South Africa are expected to observe highest growth with CAGR ranging between 11.2% to 14.6%.
  • Transition like Evolution towards Automated Cryopreservation Systems is expected to add $700.0 million to the Cryopreservation Systems market growth by 2030
  • The Cryopreservation Systems market is set to add $5.0 billion between 2024 and 2034, with industry players targeting Organ Transplants & In Vitro Fertilization Therapeutic Application projected to gain a larger market share.
  • With Biomedical advancements, and Upsurge in cord blood banking, Cryopreservation Systems market to expand 202% between 2024 and 2034.
cryopreservation systems market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032

Opportunities in the Cryopreservation Systems

The growing focus on healthcare and genomics has resulted in a rise in the need for biobanking services and advanced cryopreservation technology to effectively store tissues for future use, in the biobanking industry—a trend that could lead to substantial market growth.

Growth Opportunities in North America and Asia-Pacific

North America Outlook

In North America, the Cryopreservation Systems market has shown remarkable growth primarily due to the increasing use of advanced preservation techniques in healthcare and research institutions. Key opportunities are mainly linked to the escalating demand in sectors such as biopharmaceuticals, regenerative medicine, and in-vitro fertilization.Nonetheless, competition is stiff with industry frontrunners such as Thermo Fisher Scientific and Merck Group dominating the market due to their broad product portfolios and robust distribution networks. Additionally, the widespread use of AI and ML in Cryopreservation Systems could serve as a significant market driver in this region, bolstering the growth further.

Asia-Pacific Outlook

In contrast, the Asia-Pacific region holds immense potential for the Cryopreservation Systems market. Higher birth rates and increasing awareness about IVF treatments are driving the demand. Moreover, the proliferating biotechnology sector, primarily in countries like China and India, presents notable opportunities for commercial cryopreservation technologies. The market certainly faces competition, but its largely from international vendors, creating a substantial space for domestic players to grow. The principal market driver in this region is anticipated to be the surge in genomic data and the necessity for its long-term storage, followed by advancements in bio-banking technology.

Market Dynamics and Supply Chain

01

Driver: Biomedical Advancements, and Technological Innovations

The remarkable progress in medicine and science has also led to a growing demand for cryopreservation systems within the field and research sector alike. These systems are also vital for ensuring the preservation of biological materials such as cells and even entire organisms. With the rise, in applications related to medicine organ transplants and tissue engineering rely heavily on these systems resultantly driving substantial growth in the market. Technological advancements in cryopreservation systems such as controlled-rate freeze-thawing, vitrification, and the development of advanced cryoprotectant solutions have also majorly impacted market dynamics. These technological breakthroughs have also made the cryopreservation of cellular products more efficient, reliable, and scalable increasing the demand for advanced cryopreservation systems.
The growing popularity of storing cord blood. A process that involves preserving stem cells from a babys cord for potential future medical treatments. has also highlighted the importance of cryopreservation systems in this field. These innovative systems have also played a role, in making cord blood storage a practical option and have also significantly contributed to the markets growth.
02

Restraint: High Cost of Cryopreservation Equipment

The significant expenses involved in establishing and running a cryopreservation system present one of the challenges for this industry sector. The high price tags attached to these cutting edge systems discourage entities and research facilities from investing in them and contribute to limiting the market size. Moreover the ongoing maintenance. The necessity for consistent power supply. Essential for preserving integrity. Further increase overall operational expenditures rendering it less attainable, for prospective users.
03

Opportunity: Technological Innovations and Opportunities in Emerging Markets

With the progress in medicine and biologics moving forward rapidly along with cell therapy advancements the importance of cryopreservation systems is increasingly vital to uphold the vitality and functionality of biological materials involved in these fields of study. These changing requirements in research may pave the way for expanded opportunities, for cryopreservation systems.
In nations such as India and China that have expanding healthcare systems and growing research structures in place can offer avenues for development in cryopreservation technology systems forming partnerships with local organizations, for manufacturing or distribution could open up strategic routes to reach these emerging markets.
04

Challenge: Tightening Regulatory Standards

Cryopreservation systems are subject to stringent regulatory standards due to their sensitive usage in storing biological samples. Regulatory bodies enact stringent measures to ensure patient safety, product quality, and efficacy. The shifting and evolving regulatory scenario presents a challenge to companies operating in this field as they are required to constantly upgrade their systems to comply with new norms.

Supply Chain Landscape

1
Raw Material Acquisition

Thermo Fisher Scientific

Merck Millipore

2
Manufacturing

Brooks Automation

Chart Industries

3
Distribution

Planer

Astero Bio

4
End-User Industry

Biotechnology

Fertility Clinics

Pharmaceuticals

*The illustration highlights the key stakeholders within the supply chain ecosystem.

Applications of Cryopreservation Systems in Stem Cell Research, Organ Transplants & In Vitro Fertilization

Stem Cell Research

Cryopreservation systems are extensively used in stem cell research. Ultralow temperature cryopreservation systems are the go-to solution in this field, as they help maintain the viability of sensitive cell cultures during long-term storage. The application offers the unique advantage of preserving samples for future studies, eliminating the need for continuous cell cultures. Key players in this field include Thermo Fisher Scientific and Brooks Life Sciences, both known for providing advanced, reliable, and efficient cryopreservation systems, thereby commanding a strong presence in the market.

In Vitro Fertilization

Cryopreservation systems are an indispensable tool in assisted reproductive technologies, more specifically in invitro fertilization clinics. They use vitrification-based cryopreservation systems to preserve sperm, oocytes, and embryos, ensuring their survival for future use. This application allows for the storage and management of genetic resources over extended periods, giving new hope to couples struggling with infertility. Notably, major companies such as Chart Industries and BioLife Solutions excel in this niche, offering high-tech, user-friendly systems that highlight their superior market standing.

Organ Transplants

Cryopreservation systems also hold crucial importance in the organ transplant field. Here, controlled-rate freezing systems are primarily used to store donated organs until a suitable recipient is found.

Recent Developments

December 2024

Thermo Fisher Scientific, a key player in the Cryopreservation Systems market, launched an innovative, high-efficiency cryopreservation system, enhancing the longevity and viability of preserved cells

October 2024

BioLife Solutions announced expansion of their cryopreservation systems production capacities to meet the escalating demand from stem cell and regenerative medicine sectors

August 2024

Merck KGaA made a strategic partnership with CryoTherapeutics to refine and extend their Cryopreservation Systems offering in the cardiovascular disease treatment landscape.

Cryopreservation systems have observed significant advancements in recent times, making great strides towards precision and efficiency in their application areas. An emerging trend influencing this realm is the rise of personalized medicine that necessitates the preservation of biological samples for extended periods. Harnessing cutting-edge cryogenic technologies, modern cryopreservation systems have set industry standards by significantly reducing sample degradation over time.

Impact of Industry Transitions on the Cryopreservation Systems Market

As a core segment of the Medical Device industry, the Cryopreservation Systems market develops in line with broader industry shifts. Over recent years, transitions such as Evolution towards Automated Cryopreservation Systems and Adoption of High-Tech Vitrification Methods have redefined priorities across the Medical Device sector, influencing how the Cryopreservation Systems market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Evolution towards Automated Cryopreservation Systems

The automation in cryopreservation systems has been a significant transition in this industry. Automated cryopreservation systems are becoming an essential part of cell therapy manufacturing to ensure standardization and efficacy in the process. With these systems, the risk of contamination reduces considerably, enhancing the safety and quality of preserved biological samples. As a result, industries associated with bio-banking, stem cell research, IVF & reproductive medicine sect all have shown an increased adoption rate for automated cryopreservation equipment. This industry transition is expected to add $700 million in the industry revenue between 2024 and 2030.
02

Adoption of High-Tech Vitrification Methods

The shift from traditional slow freezing techniques to advanced vitrification methods marks another significant transition in the cryopreservation systems industry. Vitrification supports a fast and uniform freezing process that eliminates the formation of destructive ice crystals and achieves a better cell survival rate. Pharmacies, biotechnological-enabled companies, and agricultural sectors are leveraging this high-tech procedure to enhance the cryopreservation of cell lines, embryos, and plant tissues, leading to improved results and yield.

Related Reports

Loading related reports...